Literature DB >> 2732241

Purine metabolism in Toxoplasma gondii.

E C Krug1, J J Marr, R L Berens.   

Abstract

We have studied the incorporation and interconversion of purines into nucleotides by freshly isolated Toxoplasma gondii. They did not synthesize nucleotides from formate, glycine, or serine. The purine bases hypoxanthine, xanthine, guanine, and adenine were incorporated at 9.2, 6.2, 5.1, and 4.3 pmol/10(7) cells/h, respectively. The purine nucleosides adenosine, inosine, guanosine, and xanthosine were incorporated at 110, 9.0, 2.7, and 0.3 pmol/10(7) cells/h, respectively. Guanine, xanthine, and their respective nucleosides labeled only guanine nucleotides. Inosine, hypoxanthine, and adenine labeled both adenine and guanine nucleotide pools at nearly equal ratios. Adenosine kinase was greater than 10-fold more active than the next most active enzyme in vitro. This is consistent with the metabolic data in vivo. No other nucleoside kinase or phosphotransferase activities were found. Phosphorylase activities were detected for guanosine and inosine; no other cleavage activities were detected. Deaminases were found for adenine and guanine. Phosphoribosyltransferase activities were detected for all four purine nucleobases. Interconversion occurs only in the direction of adenine to guanine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732241

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii.

Authors:  L D Sibley; A J LeBlanc; E R Pfefferkorn; J C Boothroyd
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

2.  Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii.

Authors:  M M Nelson; A R Jones; J C Carmen; A P Sinai; R Burchmore; J M Wastling
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

3.  Double-stranded RNA specific to adenosine kinase and hypoxanthine-xanthine-guanine-phosphoribosyltransferase retards growth of Toxoplasma gondii.

Authors:  Li Yu; Yu-Feng Gao; Xia Li; Zeng-Pei Qiao; Ji-Long Shen
Journal:  Parasitol Res       Date:  2008-10-03       Impact factor: 2.289

Review 4.  Toxoplasma gondii and ocular toxoplasmosis: pathogenesis.

Authors:  C E Pavesio; S Lightman
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

5.  A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.

Authors:  Soumitra Mohanty; Lakshmanan Jagannathan; Geetanjali Ganguli; Avinash Padhi; Debasish Roy; Nader Alaridah; Pratip Saha; Upendra Nongthomba; Gabriela Godaly; Ramesh Kumar Gopal; Sulagna Banerjee; Avinash Sonawane
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

6.  CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.

Authors:  M B Purner; R L Berens; P B Nash; A van Linden; E Ross; C Kruse; E C Krug; T J Curiel
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.

Authors:  M H el Kouni; V Guarcello; O N Al Safarjalani; F N Naguib
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

8.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28

9.  Microarray-based transcriptional profiling of Eimeria bovis-infected bovine endothelial host cells.

Authors:  Anja Taubert; Klaus Wimmers; Siriluck Ponsuksili; Cristina Arce Jimenez; Horst Zahner; Carlos Hermosilla
Journal:  Vet Res       Date:  2010-07-12       Impact factor: 3.683

10.  Localization of azithromycin in Toxoplasma gondii-infected cells.

Authors:  J C Schwab; Y Cao; M R Slowik; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.